Open Access

Increased cyclooxygenase-2 and nuclear factor-κB/p65 expression in mouse hippocampi after systemic administration of tetanus toxin

  • Authors:
    • Bing Chun Yan
    • Yong Hwan Jeon
    • Joon Ha Park
    • In Hye Kim
    • Jeong‑Hwi Cho
    • Ji Hyeon Ahn
    • Bai Hui Chen
    • Hyun‑Jin Tae
    • Jae‑Chul Lee
    • Ji Yun Ahn
    • Dong Won Kim
    • Jun Hwi Cho
    • Moo‑Ho Won
    • Seongkweon Hong
  • View Affiliations

  • Published online on: October 26, 2015     https://doi.org/10.3892/mmr.2015.4490
  • Pages: 7837-7844
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Brain inflammation has a crucial role in various diseases of the central nervous system. The hippocampus in the mammalian brain exerts an important memory function, which is sensitive to various insults, including inflammation induced by exo/endotoxin stimuli. Tetanus toxin (TeT) is an exotoxin with the capacity for neuronal binding and internalization. The present study investigated changes in inflammatory mediators in the mouse hippocampus proper (CA1‑3 regions) and dentate gyrus (DG) after TeT treatment. The experimental mice were intraperitoneally injected with TeT at a low dosage (100 ng/kg), while the control mice were injected with the same volume of saline. At 6, 12 and 24 h after TeT treatment, changes in the hippocampal levels of inflammatory mediators cyclooxygenase‑2 (COX‑2) and nuclear factor kappa‑B (NF‑κB/p65) were assessed using immunohistochemical and western blot analysis. In the control group, moderate COX‑2 immunoreactivity was observed in the stratum pyramidal (SP) of the CA2‑3 region, while almost no expression was identified in the CA1 region and the DG. COX‑2 immunoreactivity was increased by TeT in the SP and granule cell layer (GCL) of the DG in a time‑dependent manner. At 24 h post‑treatment, COX‑2 immunoreactivity in the SP of the CA1 region and in the GCL of the DG was high, and COX‑2 immunoreactivity in the SP of the CA2/3 region was highest. Furthermore, the present study observed that NF‑κB/p65 immunoreactivity was obviously increased in the SP and GCL at 6, 12 and 24 h after TeT treatment. In conclusion, the present study demonstrated that systemic treatment with TeT significantly increased the expression of COX-2 and NF-κB/p65 in the mouse hippocampus, suggesting that increased COX‑2 and NF-κB/65 expression may be associated with inflammation in the brain induced by exotoxins.
View Figures
View References

Related Articles

Journal Cover

December-2015
Volume 12 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan BC, Jeon YH, Park JH, Kim IH, Cho JH, Ahn JH, Chen BH, Tae HJ, Lee JC, Ahn JY, Ahn JY, et al: Increased cyclooxygenase-2 and nuclear factor-κB/p65 expression in mouse hippocampi after systemic administration of tetanus toxin. Mol Med Rep 12: 7837-7844, 2015
APA
Yan, B.C., Jeon, Y.H., Park, J.H., Kim, I.H., Cho, J., Ahn, J.H. ... Hong, S. (2015). Increased cyclooxygenase-2 and nuclear factor-κB/p65 expression in mouse hippocampi after systemic administration of tetanus toxin. Molecular Medicine Reports, 12, 7837-7844. https://doi.org/10.3892/mmr.2015.4490
MLA
Yan, B. C., Jeon, Y. H., Park, J. H., Kim, I. H., Cho, J., Ahn, J. H., Chen, B. H., Tae, H., Lee, J., Ahn, J. Y., Kim, D. W., Cho, J. H., Won, M., Hong, S."Increased cyclooxygenase-2 and nuclear factor-κB/p65 expression in mouse hippocampi after systemic administration of tetanus toxin". Molecular Medicine Reports 12.6 (2015): 7837-7844.
Chicago
Yan, B. C., Jeon, Y. H., Park, J. H., Kim, I. H., Cho, J., Ahn, J. H., Chen, B. H., Tae, H., Lee, J., Ahn, J. Y., Kim, D. W., Cho, J. H., Won, M., Hong, S."Increased cyclooxygenase-2 and nuclear factor-κB/p65 expression in mouse hippocampi after systemic administration of tetanus toxin". Molecular Medicine Reports 12, no. 6 (2015): 7837-7844. https://doi.org/10.3892/mmr.2015.4490